))
22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke
Manage episode 312718372 series 3243074
Sisällön tarjoaa Stroke FM. Stroke FM tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
This is an official Canadian Stroke Consortium (CSC) - StrokeFM Podcast episode:
Neuroprotection and stroke care
What does the future hold? Where are we coming from and where are we going? These and other exciting topics of discussion in conversation with Dr. Michael Hill (Calgary Stroke Program) as we chat about ESCAPE NA1 and ESCAPE NEXT. ESCAPE-NEXT is a multi-centre, randomized, double-blinded, placebo-controlled, parallel Group, single-dose trial designed to determine the efficacy and safety of Nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. This is an official CSC Podcast episode (Season 2, Episode 8). As usual, see our Disclaimer about this educational podcast.
Please follow us on Twitter: @strokefm
Subscribe to the Podcast and give us 5 stars!
Apple PodCast
Spotify PodCast
27 jaksoa
Jaa
